Clinical trial
Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With…
NCT00383370 · Regeneron Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00383370 |
|---|---|
| Title | Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD |
| Official title | A Trial to Assess the Safety and Tolerability of Repeated Doses of Intravitreal Administration of Two VEGF Trap Formulations in Subjects With Neovascular Age Related Macular Degeneration |
| Lead sponsor | Regeneron Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neovascular Age Related Macular Degeneration |
| Intervention type | Biological, Drug |
| Interventions | VEGF Trap |
| Enrollment | 20 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Oct 3, 2006 |
| Last update posted | Apr 21, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: